Article type
Year
Abstract
Background:
Overall prognosis (OP) refers to the average course or future outcomes of individuals with a particular exposure or a health-related condition. OP estimates are important tools for individualizing the estimation of benefits and harms of interventions, developing clinical practice recommendations, and guiding future research. To estimate OP, systematic reviews summarize prognosis outcome estimates extracted from various primary studies or data sources. Although the assessment of risk of bias (RoB) is an integral part of any systematic review, there is no specific tool for assessing RoB in OP estimates reported by primary studies.
Objectives:
We aim to develop a tool to assess the RoB in OP estimates obtained from primary studies.
Methods:
A steering group (StG) of eight experts on prognosis, RoB assessment, and systematic reviews developed a first draft based on available tools and refined it through iterative discussions. We obtained external feedback by surveying members of stakeholder groups. The StG is currently considering the survey feedback through iterative discussions.
Results:
We decided to separate the tool into assessments for applicability and RoB. We address the domains “participants,” “outcome,” “analysis,” and “selective reporting” for RoB and the domains “participants’ setting” and “outcome” for applicability. We introduce each block of related questions with an elaboration box, followed by factually phrased signaling questions that can be answered with “yes,” “probably yes,” “no,” “probably no,” and “not sufficient information.” For the RoB assessment, the participants domain aims at detecting whether the participant sample of an OP study was selective by covering recruitment strategy and inappropriate exclusions of participants. The second domain assesses whether the outcome was defined and measured appropriately and whether the frequency of outcome assessment was appropriate. The analysis domain aims to detect flaws regarding attrition and analytical methods, and the last domain covers selective reporting.
Conclusions:
Manifold discussions between StG members reflect the complexity of distinguishing between RoB and applicability. Currently, we are finalizing the remaining domains, the creation of flow charts to facilitate domain-based decision-making, piloting of the tool, and external consolidation via subsequent surveys.
Overall prognosis (OP) refers to the average course or future outcomes of individuals with a particular exposure or a health-related condition. OP estimates are important tools for individualizing the estimation of benefits and harms of interventions, developing clinical practice recommendations, and guiding future research. To estimate OP, systematic reviews summarize prognosis outcome estimates extracted from various primary studies or data sources. Although the assessment of risk of bias (RoB) is an integral part of any systematic review, there is no specific tool for assessing RoB in OP estimates reported by primary studies.
Objectives:
We aim to develop a tool to assess the RoB in OP estimates obtained from primary studies.
Methods:
A steering group (StG) of eight experts on prognosis, RoB assessment, and systematic reviews developed a first draft based on available tools and refined it through iterative discussions. We obtained external feedback by surveying members of stakeholder groups. The StG is currently considering the survey feedback through iterative discussions.
Results:
We decided to separate the tool into assessments for applicability and RoB. We address the domains “participants,” “outcome,” “analysis,” and “selective reporting” for RoB and the domains “participants’ setting” and “outcome” for applicability. We introduce each block of related questions with an elaboration box, followed by factually phrased signaling questions that can be answered with “yes,” “probably yes,” “no,” “probably no,” and “not sufficient information.” For the RoB assessment, the participants domain aims at detecting whether the participant sample of an OP study was selective by covering recruitment strategy and inappropriate exclusions of participants. The second domain assesses whether the outcome was defined and measured appropriately and whether the frequency of outcome assessment was appropriate. The analysis domain aims to detect flaws regarding attrition and analytical methods, and the last domain covers selective reporting.
Conclusions:
Manifold discussions between StG members reflect the complexity of distinguishing between RoB and applicability. Currently, we are finalizing the remaining domains, the creation of flow charts to facilitate domain-based decision-making, piloting of the tool, and external consolidation via subsequent surveys.